{
    "organizations": [],
    "uuid": "d2a7a704807df34cddacff852046979f2e3a73ca",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-three-archs-shares-of-acelrx-stock/brief-three-archs-shares-of-acelrx-stock-acquired-in-transaction-led-by-leerink-revelation-partners-and-industry-ventures-idUSFWN1SU0MC",
    "ord_in_thread": 0,
    "title": "BRIEF-Three Arch's Shares Of AcelRx Stock Acquired In Transaction Led By Leerink Revelation Partners And Industry Ventures",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 23 (Reuters) - AcelRx Pharmaceuticals Inc:\n* THREE ARCH’S SHARES OF ACELRX COMMON STOCK ACQUIRED IN A PRIVATE TRANSACTION LED BY LEERINK REVELATION PARTNERS AND INDUSTRY VENTURES\n* ACELRX PHARMACEUTICALS INC - NO CHANGES WERE MADE TO COMPOSITION OR SIZE OF ACELRX’S BOARD OF DIRECTORS\n* ACELRX PHARMACEUTICALS - ALL OF CO’S SHARES OWNED BY THREE ARCH ACQUIRED BY INVESTORS LED BY LEERINK REVELATION PARTNERS, INDUSTRY VENTURES\n* ACELRX PHARMACEUTICALS INC - REMAIN ON TRACK TO ACHIEVE REMAINING KEY MILESTONES THIS YEAR\n* ACELRX PHARMACEUTICALS INC - THREE ARCH FUNDS IN DISSOLUTION PROCESS AND ARE EACH FINALIZING LIQUIDATION OF THEIR ENTIRE RESPECTIVE PORTFOLIOS\n* ACELRX PHARMACEUTICALS INC - THREE ARCH FUNDS REMAINING ASSETS COMPRISED OF 9.4 MILLION SHARES IN AGGREGATE ACROSS ALL OF FUNDS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-23T19:27:00.000+03:00",
    "crawled": "2018-05-24T20:37:48.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "acelrx",
        "pharmaceutical",
        "inc",
        "three",
        "arch",
        "share",
        "acelrx",
        "common",
        "stock",
        "acquired",
        "private",
        "transaction",
        "led",
        "leerink",
        "revelation",
        "partner",
        "industry",
        "venture",
        "acelrx",
        "pharmaceutical",
        "inc",
        "change",
        "made",
        "composition",
        "size",
        "acelrx",
        "board",
        "director",
        "acelrx",
        "pharmaceutical",
        "co",
        "share",
        "owned",
        "three",
        "arch",
        "acquired",
        "investor",
        "led",
        "leerink",
        "revelation",
        "partner",
        "industry",
        "venture",
        "acelrx",
        "pharmaceutical",
        "inc",
        "remain",
        "track",
        "achieve",
        "remaining",
        "key",
        "milestone",
        "year",
        "acelrx",
        "pharmaceutical",
        "inc",
        "three",
        "arch",
        "fund",
        "dissolution",
        "process",
        "finalizing",
        "liquidation",
        "entire",
        "respective",
        "portfolio",
        "acelrx",
        "pharmaceutical",
        "inc",
        "three",
        "arch",
        "fund",
        "remaining",
        "asset",
        "comprised",
        "million",
        "share",
        "aggregate",
        "across",
        "fund",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}